INTRODUCTION: Inhaled nitric oxide (iNO2) is an effective pulmonary vasodilator in treatment of pulmonary hypertension. Prior studies demonstrated a decrease in pulmonary arterial pressure and pulmonary vascular resistance and increase in cardiac output at a dosage between 20-80ppm. However, the effect of lower dosage in conjunction with high flow oxygen has not been well-studied.
To read this article in full you will need to make a payment
© 2011 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.